Zoetis Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones

2025.12.04 21:50

I'm PortAI, I can summarize articles.

Zoetis Inc. (ZTS) shares fell 1.76% to $120.41 on Thursday, marking the fourth consecutive day of losses. The stock underperformed compared to competitors like Merck & Co. Inc. and IDEXX Laboratories Inc. Trading volume was higher than the 50-day average. Zoetis is 33.79% below its 52-week high of $181.85. The S&P 500 rose 0.11%, while the Dow Jones fell 0.07%.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Zoetis Inc. (ZTS) slid 1.76% to $120.41 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.11% to 6,857.12 and the Dow Jones Industrial Average falling 0.07% to 47,850.94. This was the stock's fourth consecutive day of losses. Zoetis Inc. closed 33.79% below its 52-week high of $181.85, which the company reached on December 13th. The stock underperformed when compared to some of its competitors Thursday, as Merck & Co. Inc. (MRK) fell 1.35% to $100.89 and IDEXX Laboratories Inc. (IDXX) fell 1.17% to $717.47. Trading volume (4.9 M) eclipsed its 50-day average volume of 4.1 M. Data source: Dow Jones Market Data, FactSet. Data compiled December 4, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-04-25 1650ET